FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to psychiatry, and can be used for prediction of metabolic syndrome in schizophrenic patients receiving antipsychotic therapy. Method includes anthropometric examination. A Rees-Eysenk index is determined. If the Rees-Eysenk index is less than 100.5, metabolic syndrome is predicted.
EFFECT: method enables reliable and convenient prediction of developing metabolic syndrome in schizophrenic patients receiving antipsychotic therapy, timely correction of treatment, higher effectiveness and quality by evaluating the Rees-Eysenk index.
1 cl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING DEVELOPMENT OF VISCERAL OBESITY IN PATIENTS WITH SCHIZOPHRENIA RECEIVING QUETIAPINE THERAPY | 2017 |
|
RU2659638C1 |
| METHOD FOR PREDICTION OF METABOLIC SYNDROME RISK WITH UNDERLYING ANTIPSYCHOTIC THERAPY IN SCHIZOPHRENIC PATIENTS | 2019 |
|
RU2722649C1 |
| DIAGNOSTIC TECHNIQUE FOR METABOLIC SYNDROME IN SCHIZOPHRENIC PATIENTS RECEIVING NEUROLEPTIC THERAPY | 2019 |
|
RU2717367C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING HYPERPROLACTINEMIA IN WOMEN WITH SCHIZOPHRENIA TAKING ANTIPSYCHOTIC THERAPY | 2023 |
|
RU2810398C1 |
| METHOD FOR SUPPORTING MEDICAL DECISIONS ON SELECTION OF ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA IN ORDER TO PREVENT AKATHISIA | 2021 |
|
RU2756614C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD FOR PREDICTING NEGATIVE CLINICAL MANIFESTATIONS IN SCHIZOPHRENIA FLOW | 2001 |
|
RU2188577C1 |
| METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
| METHOD FOR PREDICTING FUNCTIONAL RESULT IN PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2757728C1 |
